StockData

Exicure, Inc. (XCUR) stock

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.08+0.01 (+0.93%)

Close on Nov 17, 2026Market cap $7.07MP/E –Yield –

Exicure EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Exicure's EPS for the twelve months ending Jun 30, 2026 was -$1.31. For fiscal 2025 it was -$0.79. The highest annual figure on record is -$0.79 in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$0.79–
FY2024Dec 31, 2024-$4.75–
FY2023Dec 31, 2023-$10.55–
FY2022Dec 31, 2022-$2.80–
FY2021Dec 31, 2021-$108.50–
FY2020Dec 31, 2020-$42.00–
FY2019Dec 31, 2019-$69.00–
FY2018Dec 31, 2018-$81.00–
FY2017Dec 31, 2017-$163.50–
FY2016Dec 31, 2016-$22405.50–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.18–
Q1 FY2026Mar 31, 2026-$0.29-159.2%
Q4 FY2025Dec 31, 2025-$0.45–
Q3 FY2025Sep 30, 2025-$0.39–
Q2 FY2025Jun 30, 2025-$0.41–
Q1 FY2025Mar 31, 2025$0.49–
Q4 FY2024Dec 31, 2024-$2.75–
Q3 FY2024Sep 30, 2024-$0.57–
Q2 FY2024Jun 30, 2024-$0.35–
Q1 FY2024Mar 31, 2024-$0.48–
Q4 FY2023Dec 31, 2023-$0.86–
Q3 FY2023Sep 30, 2023-$3.04–
Q2 FY2023Jun 30, 2023-$3.40–
Q1 FY2023Mar 31, 2023-$3.50–
Q3 FY2022Sep 30, 2022-$5.20–
Q2 FY2022Jun 30, 2022-$8.30–
Q1 FY2022Mar 31, 2022-$10.35–
Q4 FY2021Dec 31, 2021-$22.92–
Q3 FY2021Sep 30, 2021-$40.05–
Q2 FY2021Jun 30, 2021-$24.30–
Q1 FY2021Mar 31, 2021-$21.00-1500.0%
Q4 FY2020Dec 31, 2020-$22.50–
Q3 FY2020Sep 30, 2020-$15.00–
Q2 FY2020Jun 30, 2020-$7.50–
Q1 FY2020Mar 31, 2020$1.50–
Q4 FY2019Dec 31, 2019-$19.50–
Q3 FY2019Sep 30, 2019-$13.50–
Q2 FY2019Jun 30, 2019-$18.00–
Q1 FY2019Mar 31, 2019-$18.00–
Q4 FY2018Dec 31, 2018-$16.50–
Q3 FY2018Sep 30, 2018-$19.50–
Q2 FY2018Jun 30, 2018-$25.50–
Q1 FY2018Mar 31, 2018-$21.00–
Q4 FY2017Dec 31, 2017-$13.50–
Q2 FY2017Aug 31, 2017-$1.50–
Q4 FY2016Dec 31, 2016-$6764.99–
Q3 FY2016Sep 30, 2016-$5413.50–

More Exicure figures

See a number that looks wrong?